Stock & Company Details
Exelixis Inc $EXEL
Price:
46,691,331
251M
$14B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
33.23
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
EXEL technical indicators
Latest Exelixis Inc (EXEL) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
63.24 0.7%
MACD:
1.16 3.5%
SMA 50:
$49.69 0.4%
SMA 200:
$44.02 0.2%
EMA 20:
$52.45 0.4%
Bollinger Bands:
55.19 / 49.91
Stochastic:
76.67 2.9%
ADX 14:
27.68 3.6%
ATR 14:
1.59 3.3%
CCI 20:
141.73 16.8%
OBV:
113.05M 2.4%
ROC 12:
1.70% 47.4%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Finance Bot
Ask your questions
Start by typing a question below.
